Market Cap 3.7B 984M 850M 799M 726M 1.37B 94.11B 1.39B 9.36B 3.66B 47.13B 3.62B 157B P/E 2026 *
19.1x
P/E 2027 * 14.8x
Enterprise Value 4.71B 1.25B 1.08B 1.02B 925M 1.74B 120B 1.77B 11.92B 4.66B 60.04B 4.61B 200B EV / Sales 2026 *
2.51x
EV / Sales 2027 * 2.37x
Free-Float
78.97%
Yield 2026 *
1.73%
Yield 2027 * 3.22%
1 day+0.52%
1 week-1.53%
Current month-1.09%
1 month+3.41%
3 months+4.24%
6 months+5.59%
Current year+18.80%
1 week 30.6
Extreme 30.6
31.6
1 month 28.6
Extreme 28.6
32
Current year 24.96
Extreme 24.96
33.12
1 year 24.96
Extreme 24.96
33.12
3 years 20.94
Extreme 20.94
42.85
5 years 20.94
Extreme 20.94
55.8
10 years 20.94
Extreme 20.94
61.4
Manager TitleAgeSince
Chief Executive Officer 58 2021-01-04
Chief Executive Officer - 2025-04-06
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 2016-04-02
Director/Board Member - 2019-04-02
Director/Board Member - 2019-04-02
Change 5-day change 1-year change 3-year change Capi.($)
+0.52%-1.53%+18.17%-22.21% 984M
-2.25%-0.47%+72.43%+119.36% 1,052B
-0.66%+0.43%+49.01%+50.11% 627B
-0.54%+1.39%+21.88%+63.83% 441B
-1.99%-3.32%+41.98%+34.08% 349B
-1.05%-2.81%+24.22%+34.67% 287B
-2.12%-3.67%-1.09%+3.11% 241B
-0.63%+1.04%+43.03%+59.10% 224B
-1.19%-3.41%-9.18%-52.41% 202B
+0.16%+3.87%+16.25%+73.27% 172B
Average -0.54%+0.17%+27.67%+36.29% 359.62B
Weighted average by Cap. -0.09%+0.31%+41.31%+62.00%

Financials

2026 *2027 *
Net sales 1.88B 500M 432M 406M 369M 694M 47.81B 705M 4.75B 1.86B 23.94B 1.84B 79.56B 1.92B 513M 443M 416M 378M 711M 49.02B 723M 4.88B 1.91B 24.55B 1.88B 81.57B
Net income 195M 51.91M 44.84M 42.13M 38.32M 72.04M 4.96B 73.23M 494M 193M 2.49B 191M 8.26B 253M 67.37M 58.19M 54.68M 49.73M 93.49M 6.44B 95.03M 641M 250M 3.23B 247M 10.72B
Net Debt 1.01B 270M 233M 219M 199M 374M 25.78B 380M 2.56B 1B 12.91B 990M 42.9B 863M 230M 198M 187M 170M 319M 21.98B 324M 2.19B 855M 11B 844M 36.57B
Logo Saudi Pharmaceutical Industries and Medical Appliances Corporation
Saudi Pharmaceutical Industries and Medical Appliances Corp SPIMACO ADDWAEIH SJSC is a Saudi Arabia based pharmaceutical company. The Company is primarily engaged in manufacturing of pharmaceutical products, medicines for human use and wholesale and retail of medicines and related products, development and marketing of medical and pharmaceutical products, research and development in medical science activities, operating and maintaining the healthcare facilities and any investments in related industries. The Company is organized into four segments which include Pharmaceutical Manufacturing, Trading and Distribution Services, Healthcare Services and Discontinued Operation. Products of the Company include tablets, capsules, syrups and suspensions, injections, creams, ointments and gels, suppositories, mouthwash and antiseptic products. The Subsidiaries of the Company include ARACOM Medical Company, Dammam Pharmaceutical Company, SPIMACO Misr Company for Distribution and others.
Employees
-
Date Price Change Volume
26-08-13 SAR 30.96 +0.52% 202,399
26-08-12 SAR 30.80 -0.58% 188,368
26-08-11 SAR 30.98 -1.46% 243,208
26-08-10 SAR 31.44 +1.55% 219,438
26-08-09 SAR 30.96 -1.53% 239,927
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
30.96SAR
Average target price
31.86SAR
Spread / Average Target
+2.92%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2070 Stock